Peter Moleman
Overview
Explore the profile of Peter Moleman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bogers J, Schulte P, Broekman T, Moleman P, de Haan L
Eur Neuropsychopharmacol
. 2018 Jul;
28(9):1024-1034.
PMID: 30025751
Long-stay patients with severe schizophrenia are frequently treated with high doses of first-generation antipsychotics (FGA). Dose reduction or switching to ziprasidone may reduce the severity of negative symptoms and side...
2.
Birkenhager T, Van den Broek W, Mulder P, Moleman P, Bruijn J
J Clin Psychopharmacol
. 2008 Mar;
28(2):166-70.
PMID: 18344726
The purpose of the present study is to compare the efficacy of imipramine in the treatment of psychotic versus nonpsychotic depression. Previous studies report varying results of monotherapy with antidepressants...
3.
Birkenhager T, Van den Broek W, Fekkes D, Mulder P, Moleman P, Bruijn J
Prog Neuropsychopharmacol Biol Psychiatry
. 2007 May;
31(5):1084-8.
PMID: 17467132
The efficacy of the addition of lithium to an established course of antidepressant treatment can be explained by a synergistic effect of the two drugs on central 5-HT neurotransmission. In...
4.
Van den Broek W, Birkenhager T, Mulder P, Mathot R, Bruijn J, Moleman P
J Clin Psychopharmacol
. 2007 Apr;
27(2):231-3.
PMID: 17414260
No abstract available.
5.
Birkenhager T, Van den Broek W, Moleman P, Bruijn J
J Clin Psychiatry
. 2006 Sep;
67(8):1266-71.
PMID: 16965206
Objective: The aim of this study was to examine the efficacy and the feasibility of a 4-step treatment algorithm for inpatients with major depressive disorder. Method: Depressed inpatients, meeting DSM-IV...
6.
Van den Broek W, Birkenhager T, Mulder P, Bruijn J, Moleman P
J Clin Psychiatry
. 2006 Mar;
67(2):263-8.
PMID: 16566622
Objective: To compare the efficacy of imipramine versus placebo in preventing relapse after successful electroconvulsive therapy (ECT) in depressive inpatients with pharmacotherapy treatment failure prior to ECT. Method: During a...
7.
Birkenhager T, Van den Broek W, Moleman P, Vulto A, Bruijn J
Psychopharmacology (Berl)
. 2005 Sep;
181(3):595-9.
PMID: 16133127
Rationale: Imipramine has often been used as positive control in studies investigating the efficacy of new antidepressants. Imipramine-controlled studies in general employ a fixed-dose design. It is unclear how many...
8.
Birkenhager T, Van den Broek W, Mulder P, Bruijn J, Moleman P
J Clin Psychiatry
. 2004 Nov;
65(11):1505-10.
PMID: 15554763
Background: The aim of this study was to examine whether phenelzine is a suitable alternative to tranylcypromine in antidepressant-resistant depression. Method: A total of 77 severely depressed in-patients, meeting the...
9.
Birkenhager T, Van den Broek W, Mulder P, Bruijn J, Moleman P
Am J Psychiatry
. 2004 Oct;
161(11):2060-5.
PMID: 15514407
Objective: This study was designed to compare the efficacy of two two-phase pharmacological treatment strategies for inpatients with DSM-IV major depressive disorder. Method: During phase I, patients participated in a...
10.
Van den Broek W, Birkenhager T, Mulder P, Bruijn J, Moleman P
Psychopharmacology (Berl)
. 2004 Jul;
175(4):481-6.
PMID: 15243735
Objective: To compare the efficacy of imipramine and fluvoxamine in inpatients from two centers suffering from a depressive disorder according to DSM IV criteria. Methods: The study included 141 patients...